BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 806243)

  • 1. Alpha1-antitrypsin concentrations in arterial and venous blood of patients with obstructive lung disease.
    Kueppers F
    Am Rev Respir Dis; 1975 Jun; 111(6):877-9. PubMed ID: 806243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
    Micksche M; Kokron O
    Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin deficiency in chronic obstructive pulmonary disease.
    Kulkarni VR; Pradhan MG; Bharaswadkar MS; Sengupta SR
    J Assoc Physicians India; 1982 May; 30(5):281-2. PubMed ID: 6820368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elastase activity of the sputum and the functional activity of serum alpha 1-antitrypsin in patients with chronic obstructive pulmonary disease].
    Zhou SW
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):269-70, 318. PubMed ID: 3266105
    [No Abstract]   [Full Text] [Related]  

  • 5. An arterio-venous study of serum alpha1-antitrypsin in patients with chronic bronchitis.
    Stockley RA; Burnett D; Bradwell AR
    Clin Chim Acta; 1978 Aug; 88(1):127-33. PubMed ID: 307994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal interaction of alpha 1-antitrypsin and leukocyte elastolytic activity in patients with chronic obstructive pulmonary disease.
    Martin WJ; Taylor JC
    Am Rev Respir Dis; 1979 Aug; 120(2):411-9. PubMed ID: 314251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha-1-antitrypsin in human pathology. Clinico-statistical data on alpha-1-antitrypsin chronic bronchopneumopathies. Personal case review].
    Dalmasso F; Cardellino G; Garbagni R
    Minerva Med; 1974 Dec; 65(89):4671-89. PubMed ID: 4548174
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum alpha-1-antitrypsin deficiency in COPD and normals.
    Talib SH; Toshniwal PR; Deshpande AD; Patil SD
    J Assoc Physicians India; 1982 May; 30(5):283-6. PubMed ID: 6820369
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha1-antitrypsin and its deficiency.
    Kueppers F; Black LF
    Am Rev Respir Dis; 1974 Aug; 110(2):176-94. PubMed ID: 4212922
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteolytic enzyme inhibition and enzyme therapy in chronic nonspecific lung diseases].
    Protsenko VA; Veselov VF; Kanchik IU; Protsenko AV
    Sov Med; 1983; (3):7-11. PubMed ID: 6190232
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of alpha 1 antitrypsin levels in chronic obstructive pulmonary disease.
    Sengupta SR; Jahagirdar VL; Dhole TN; Pradhan MG
    Indian J Chest Dis Allied Sci; 1983; 25(4):280-3. PubMed ID: 6332777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum alpha 1-antitrypsin and the distribution of its phenotypes in an apparently normal Spanish population and in patients with severely developed chronic obstructive pulmonary disease].
    Sueiro Bendito A; Fernández Rubio E; Díaz Enríquez M; Picher Núñez J; Pérez Rodríguez E; García Rull S
    Rev Clin Esp; 1986 Jun; 179(2):59-64. PubMed ID: 3488568
    [No Abstract]   [Full Text] [Related]  

  • 14. Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors.
    Dawson A; Allardyce M; Allan TM; Ogston D; Kerridge DF; Lewis HB
    Acta Haematol; 1976; 56(1):19-26. PubMed ID: 60867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha1-Antitrypsin and alpha2-macroglobulin in newborn infants. I. The influence of perinatal complications.
    Göbel U; Petrich C; von Voss H; Schmelzer L
    Eur J Pediatr; 1978 Sep; 129(2):117-24. PubMed ID: 79486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary veno-arterial alpha 1 protease inhibitor differences in patients with chronic lung disease].
    Ishizaki T; Azuma H; Takahashi H; Amejima S; Kishi Y; Sasaki F; Miyabo S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jan; 26(1):3-9. PubMed ID: 3259645
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological changes in the exacerbated form of chronic obstructive pulmonary disease].
    Marinov Kh; Balanova A; Nikolov K; Baleva M; Terzieva Ts
    Vutr Boles; 1986; 25(2):60-3. PubMed ID: 2424179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship of chronic obstructive pulmonary disease, diabetes melitus and serum alpha-1-antitrypsin.
    Kulpati DD; Batra AK; Gupta PS
    Indian J Chest Dis Allied Sci; 1979 Jan; 21(1):24-30. PubMed ID: 316421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of alpha 1-antitrypsin and alpha 2-macroglobulin in workers exposed to byssinogenic dusts].
    Barbu Z; Szabó S; Barbu E; Szabó A; Lakatos L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(1):17-22. PubMed ID: 77544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.